title: Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement.
abstract: BACKGROUND
  Although guidelines now recommend polytherapy to achieve blood pressure targets, little is know about which antihypertensive drugs are combined in clinical practice.
  
  
  OBJECTIVE
  To examine current practices for the coprescribing of antihypertensive agents.
  
  
  METHODS
  A population-based cohort study was performed using linked administrative databases on all Ontario residents 66 years of age or older who were newly treated for hypertension between July 1, 1994, and March 31, 2002, and did not have diabetes or other relevant comorbidities. All patients were followed for two years to determine which antihypertensives were prescribed concurrently.
  
  
  RESULTS
  Of the 166,018 patients in the described cohort, 1819 (1%) were prescribed a combination therapy tablet as their first-line therapy. The number of patients prescribed antihypertensive polytherapy within the first two years of diagnosis increased from 2071 (21%) of the 9825 hypertensive patients starting treatment in the second half of 1994 to 2578 (37%) of the 6988 hypertensive patients beginning treatment in the first quarter of 2002 (P<0.0001). Overall, 11,003 (27%) of polytherapy prescriptions were for drugs without additive hypotensive effects when combined and this proportion did not change over time.
  
  
  CONCLUSIONS
  Although there has been an increase in the use of polytherapy in elderly hypertensive patients without comorbidities in Ontario over the past decade, more than one-quarter of the two drugs prescribed together have not been proven to have additive hypotensive effects. Because this likely contributes to suboptimal blood pressure control rates, future guidelines and educational programs should devote increased attention to the choice of optimal polytherapy combinations.
authors: Department of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada.
authors: Norman R C
authors: NR
authors: Campbell
authors: Finlay A
authors: FA
authors: McAlister
authors: Minh
authors: M
authors: Duong-Hua
authors: Karen
authors: K
authors: Tu
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D019992:Databases as Topic; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017723:Drug Utilization Review; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D009864:Ontario; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011446:Prospective Studies
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics
references: JAMA. 2003 May 14;289(18):2363-9
references: 12746359
references: Lancet. 2005 Sep 10-16;366(9489):907-13
references: 16154017
references: J Am Coll Cardiol. 2004 Aug 4;44(3):E1-E211
references: 15358047
references: Cardiovasc Drugs Ther. 1988 Mar;1(6):657-60
references: 3154330
references: Drugs. 1995 Sep;50(3):560-86
references: 8521773
references: Lancet. 2002 Mar 23;359(9311):1004-10
references: 11937179
references: CMAJ. 2006 Jun 6;174(12):1737-42
references: 16754904
references: J Hypertens. 2003 Jun;21(6):1055-76
references: 12777939
references: Am J Hypertens. 1996 Dec;9(12 Pt 2):187S-191S
references: 8968432
references: J Hypertens. 2004 Feb;22(2):425-30
references: 15076203
references: J Hum Hypertens. 1997 Apr;11(4):249-50
references: 9185031
references: Lancet. 1999 Jun 12;353(9169):2008-13
references: 10376615
references: J Hypertens. 2002 Jul;20(7):1255-7
references: 12131513
references: Lancet. 2004 Jun 19;363(9426):2022-31
references: 15207952
references: J Cardiovasc Pharmacol. 1983 Nov-Dec;5(6):1083-5
references: 6196558
references: Am J Hypertens. 2001 Sep;14(9 Pt 1):963-8
references: 11587165
references: Eur Heart J. 2005 Feb;26(4):384-416
references: 15681577
references: BMJ. 2003 Jun 28;326(7404):1419
references: 12829553
references: Am J Hypertens. 2003 Nov;16(11 Pt 2):36S-40S
references: 14625159
references: J Hypertens Suppl. 1990 Sep;8(4):S83-6
references: 2258790
references: Can Fam Physician. 2002 Oct;48:1662-5
references: 12449551
references: J Hypertens. 2003 Jun;21(6):1011-53
references: 12777938
references: J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):393-404
references: 12461301
references: J Hypertens. 1996 Aug;14(8):1041-5
references: 8884561
references: J Hum Hypertens. 1998 Nov;12(11):761-3
references: 9844947
references: Eur J Clin Pharmacol. 1988;34(3):249-53
references: 3294021
references: Am J Hypertens. 1989 Mar;2(3 Pt 1):154-7
references: 2522008
references: BMJ. 1992 Feb 15;304(6824):405-12
references: 1445513
references: CMAJ. 1997 May 1;156(9):1273-87
references: 9145054
references: J Hypertens Suppl. 1989 Dec;7(6):S250-1
references: 2698934
references: Circulation. 2006 Jan 17;113(2):213-21
references: 16391156
references: J Hypertens. 2005 Apr;23(4):883-9
references: 15775795
references: J Clin Pharmacol. 1987 Jan;27(1):41-5
references: 3316303
references: BMJ. 2003 Jun 28;326(7404):1427
references: 12829555
references: Lancet. 1998 Jun 13;351(9118):1755-62
references: 9635947
references: J Clin Hypertens (Greenwich). 2003 Sep-Oct;5(5):330-5
references: 14564133
references: Arch Intern Med. 2005 Jun 27;165(12):1410-9
references: 15983291
references: Curr Hypertens Rep. 2001 Jun;3(3):203-8
references: 11353570
references: J Hum Hypertens. 1995 Oct;9(10):791-6
references: 8576893
references: Drugs. 1988 Oct;36(4):387-428
references: 3069435
references: J Hum Hypertens. 1990 Apr;4(2):157-9
references: 2338688
references: Hypertension. 2005 Jun;45(6):1113-8
references: 15851629
references: BMJ. 1998 Sep 12;317(7160):703-13
references: 9732337
references: Hypertension. 2005 May;45(5):880-6
references: 15809363
references: JAMA. 2003 May 21;289(19):2534-44
references: 12759325
references: JAMA. 2003 May 21;289(19):2560-72
references: 12748199
references: J Hum Hypertens. 2004 Mar;18(3):139-85
references: 14973512
references: Circulation. 2005 Sep 20;112(12):e154-235
references: 16160202
references: Can J Cardiol. 2005 Jun;21(8):657-72
references: 16003449
references: Lancet. 2005 Oct 29-Nov 4;366(9496):1545-53
references: 16257341
references: Hypertension. 2006 Jan;47(1):22-8
references: 16344380
references: Clin Exp Hypertens A. 1988;10(5):791-800
references: 3180489